Heterogeneity of Circulating Tumor Cell-Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response.

Cancer Res · 2021 · PMC9397625 · PMID 34711609

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

In metastatic breast cancer, there was a clear trend for selection of cells with CTC gains, starting from lower frequency clones in primary tumors to almost completely making up the metastatic tumors.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.